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Abstract We determined the ratio of A'-glycolylneuraminic acid 
(Neu5Gc) to TV-acetylneuraminic acid (Neu5Ac) in swine 
respiratory epithelia by fluorometric high-performance liquid 
chromatography, and examined the binding specificity of swine 
influenza virus strains for gangliosides containing different 
molecular species of sialic acid (Neu5Ac and Neu5Gc), and for 
bovine erythrocyte sialoglycoprotein 2 (GP-2) containing 
Neu5Gc as its predominate sialic acid (96% of total sialic 
acids). The presence of Neu5Gc, which had not been detected in 
human tracheal epithelia, and Neu5Ac in swine tracheal epithelia 
was observed in a 1:1 ratio. The swine influenza virus HI and H3 
isolates tested, except for A/swine/Iowa/15/30 (H1N1), displayed 
a marked binding ability for sialylsugar chains containing 
Neu5Gc compared with that of the human influenza virus 
strains. These results suggest that swine influenza viruses 
recognize sialylsugar chains containing the molecular species of 
sialic acid present predominantly in the swine tracheal epithe-
lium. 
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1. Introduction 
Influenza A viruses infect many animal species including 
horses, birds, pigs, and humans. The interaction of influenza 
A virus and a host cell is mediated by a viral spike glycopro-
tein, the hemagglutinin which recognizes glycoproteins and 
glycolipids containing terminal sialic acid residues [1-5]. The 
binding specificity of influenza A virus for a host cell receptor 
is an important factor in the host range and tissue tropism. 
Human strains preferentially recognize the terminal A^-acetyl-
neuraminic acid (Neu5Ac)-a-2,6-D-galactose (Gal) linkage in 
sialo-sugar chains, whereas the hemagglutinin of avian and 
equine strains preferentially recognizes terminal Neu5Ac-cc-
2,3-Gal sequences [6-9]. It was reported that the presence of 
a Neu5Ac-oc-2,6-Gal sequence which was found on the surface 
of the human tracheal epithelium would select for the receptor 
specificity of human influenza A virus strains, and would be a 
determinant of the host range of viruses [10]. 
Sialic acids which were found in animals were classified into 
*Corresponding author. Fax: (81) (54) 264-5721. 
2 major species, Neu5Ac and /V-glycolylneuraminic acid 
(Neu5Gc), in construction of the C-5 amino group [11]. The 
ratio between Neu5Gc and Neu5Ac in tissues varies among 
animal species and their tissues. Neu5Ac is widely found in 
various animal tissues. By contrast, Neu5Gc has not been 
detected in human tissues under normal conditions [11-13]. 
We determined the ratio of Neu5Gc to Neu5Ac in pig respi-
ratory epithelia by fluorometric high-performance liquid chro-
matography (HPLC), and examined the binding specificity of 
swine influenza viruses for gangliosides containing different 
molecular species of sialic acid, and for bovine sialoglycopro-
tein 2 (GP-2) containing I-active oligosaccharides with 
Neu5Gccc-2,3-Gal [14-16]. In addition, the binding specificity 
of swine influenza virus isolates for sialic acid linkage was 
determined using water-soluble polymers containing different 
sialic acid linkages. Human H1N1 and H3N2 strains prefer-
entially recognized oligosaccharides with Neu5Ac as previ-
ously reported [3,5,17]. On the other hand, 4 swine H1N1 
and H3N2 strains tested, except for A/swine/Iowa/15/30 
(H1N1), recognized sugar chains containing Neu5Gc, which 
were detected in the mucosal epithelia of swine trachea, as 
well as Neu5Ac. The results indicate that swine influenza vi-
ruses preferentially recognize the oligosaccharides containing 
the principal molecular species of sialic acid which is existent 
on the host cells, and that the binding specificity of influenza 
A virus for sialic acid molecular species may be an important 
factor for restricting the virus host range. 
2. Materials and methods 
2.1. Influenza virus 
Influenza virus A/swine/Kanagawa/1/92 (H1N2), A/swine/Italy/309/ 
83 (H3N2), A/swine/Hokkaido/2/81 (H1N1), A/swine/Colorado/77 
(H3N2), A/swine/Iowa/15/30 (H1N1), A/PR/8/34 (H1N1), A/Aichi/2/ 
68 (H3N2), and A/Memphis/1/71 (H3N2) were propagated in the 
allantoic cavity of 11-day-old chicken eggs for 48 h at 35°C and 
purified by sucrose density gradient centrifugation [18]. Viral hemag-
glutination units (HAU) were determined at 4°C in microtiter plates 
as previously described [2]. 
2.2. Swine and human tracheal epithelia 
Human tracheal epithelia were obtained from normal tracheas of 
patients (4 males and 1 female, 67-72 years old) who died of disease (2 
gastric cancers, 2 pancreatic cancers, and diabetes). Swine tracheal 
epithelia were from the Shizuoka municipal meat works. 
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2.3. Glycoconjugate polymer 
Glycoconjugate polymer having a Neu5Aca-2,3-Galp-l,4-GlcNAc 
(Neu5Aca2,3LacNAcPA) linkage was enzymatically prepared by 
stepwise sugar-elongation on a water-soluble GlcNAc-bearing poly-
acrylamide as previously described [19]. The polymer having Neu5Aca-
2,6-Gal(3-l,4-GlcNAc (Neu5Aca2,6LacNAcPA) linkage was prepared 
by sialylation with rat liver sialyltransferase (Sigma). 
2.4. TLCIvirus overlay assay 
Gangliosides (0.5^4 nmol) were developed on silica gel plastic plates 
(Polygram Sil G, Macherey-Nagel, Germany) using a solvent system 
of chloroform/methanol/12 mM MgC^ (5:4:1, v/v). Gangliosides 
were visualized by spraying the plate with the resorcinol-HCl reagent 
[20]. Immunochemical detection of virions on thin-layer plates was 
performed as described in [5,6,21]. 
2.5. Fluorometric HPLC method for determination of sialic acid species 
Fluorometric determination of Neu5Ac and Neu5Gc was con-
ducted by the HPLC method using l,2-diamino-4,5-methylenedioxy-
benzene (DMB) as previously described [22]. Human and swine tra-
cheal epithelia were washed with cold PBS and lyophilized. Each 
tracheal epithelium (10 mg) was hydrolyzed with 200 ul of 25 mM 
sulfuric acid. The hydrolysate was reacted with DMB reagent and 
heated at 60°C for 2.5 h in the dark to develop the fluorescence of 
sialic acids. A 10 ul aliquot of the resulting solution was used for 
determination of sialic acids. For the establishment of calibration 
curves, standard mixtures of Neu5Ac and Neu5Gc (Sigma, USA) 
were used. 
2.6. Sialoglycoprotein 2 (GP-2) 
GP-2 was isolated from bovine erythrocyte membranes as described 
[14-16]. 
2.7. Hemagglutination inhibition assay 
A hemagglutination inhibition (HAI) assay with glycoconjugate 
polymers was performed according to [15,17]. 
2.8. Virus hemadsorption assay with GP-2 immobilized microplates 
PBS (50 ul) containing GP-2 (20 ug/ml) was added to each micro-
titer well (Immuno plate MaxiSorp, Nunc, Denmark) and incubated 
at 37°C for 5 h. The solution was removed and the remaining binding 
sites on the wells were blocked with 250 JJ.1 of PBS containing 0.01% 
of a blocking reagent (Block Ace, Snow Brand, Japan) at 4°C for 12 
h. After washing with PBS, serial 2-fold dilutions of influenza virus 
(50 ul containing 210 HAU) in 0.01% (w/v) gelatin-PBS were added to 
the wells. The microplate was incubated at 4°C for 12 h. After wash-
ing with PBS 5 times, 25 ul of 0.01% (w/v) gelatin-PBS and 25 ul of 
0.5% (v/v) chicken erythrocytes were added to each well, mixed and 
allowed to settle at 4°C for 1 h. The maximum dilution of virus 
showing hemadsorption was defined as the virus hemadsorption 
(VH) titer. As a negative control, each influenza virus was added to 
the asialo-GP-2 immobilized wells instead of GP-2. Asialo-GP-2 was 
prepared by treatment with proteinase-free sialidase (Arthrobacter ure-
afaciens, Nacalai Tesque) as previously described [17]. 
3. Results 
3.1. Determination of Neu5Ac and Neu5Gc in swine and human 
tracheal epithelia 
As shown in Fig. 1, peaks ascribable to Neu5Ac and 
Neu5Gc were detected in the chromatogram obtained for 
swine tracheal epithelia. The concentrations of Neu5Ac and 
Neu5Gc in the epithelia were 74.6 ± 17.9 and 84.0 ± 17.6 pmol/ 
mg (mean values ± standard deviation, n = 5), and the ratio of 
Neu5Ac and Neu5Gc was approx. 1:1 as shown in Table 1. 
On the other hand, only the peak ascribable to Neu5Ac was 
detected in the chromatogram obtained for human tracheal 
epithelia. In addition, no trace of the peak ascribable to 
Neu5Gc was detected in those, even at higher detector sensi-
tivities (data not shown). 
3.2. Binding of swine influenza viruses to gangliosides 
containing different molecular species of sialic acid 
TLC/virus overlay assays with II3Neu5AcLacCer (Neu5-
AcGM3) and II3Neu5GcLacCer (Neu5GcGM3) were used 
to determine the binding activity of 3 swine influenza viruses. 
As shown in Fig. 2, 2 swine HI influenza virus strains, A/ 
swine/Hokkaido/2/81 (H1N1) and A/swine/Kanagawa/1/92 
(H1N2) except for A/swine/Iowa/15/30 (H1N1) recognized 
not only Neu5AcGM3 but also Neu5GcGM3. In contrast 
with these isolates, human strains, A/PR/8/34 (H1N1) and 
A/Memphis/1/71 (H3N2) preferentially bound to Neu5-
AcGM3, but not to Neu5GcGM3, which contains terminal 
Neu5Gc as reported previously [3,5,6,17]. 
3.3. Sialic acid linkage specificity for swine influenza viruses 
The binding specificity of 5 swine and 3 human influenza 
virus HI and H3 isolates was determined by HAI assay using 
glycoconjugate polymers containing 2 types of sialo-sugar 
linkage Neu5Acrx2,3LacNAcPA or Neu5Acoc2,6LacNAcPA. 
As shown in Table 2, hemagglutination of the swine HI and 
H3 isolates, except for A/swine/I owa/15/30 (H1N1), was sen-
sitive to inhibition by Neu5Acrx2,6LacNAcPA. As compared 
with the 4 isolates, A/swine/Iowa/15/30 (H1N1) was preferen-
tially sensitive to inhibition by Neu5Aca2,3LacNAcPA. Hu-
man influenza virus A/PR/8/34 preferentially recognizes the 
Neu5Acrx2,3Gal linkage in sialo-sugar chains over the Neu5-
Aca2,6Gal linkage, whereas A/Aichi/2/68 and A/Memphis/1/ 
71 preferentially recognize the Neu5Accc2,6Gal linkage, as 
described previously [3,5,6,17]. The binding specificity of the 
human strains determined by HAI assay using the polymers 
concurred with previous data. 
3.4. Binding of swine influenza viruses to sialoglycoprotein 2 
containing N-glycolylneuraminic acid 
Differences in the binding specificity of swine and human 
influenza viruses for structures of sialic acid residues were 
confirmed by the ability of the viruses to bind bovine 
erythrocyte sialoglycoprotein 2 (GP-2) containing the 
Neu5Gca2-3Gal sequence and I-active oligosaccharides with 
Neu5Gc as its predominate sialic acid (96% of the total sialic 
acids) [14-16,23]. Swine and human influenza A virus isolates 
exhibited marked differences in their ability to bind GP-2 
(Table 3). Swine HI and H3 isolates except for A/swine/ 
Iowa/15/30 bound to the microplate coated with GP-2. 
In contrast, human strains had a poor binding ability for 
GP-2. 
Table 1 
Concentration of Neu5Ac and Neu5Gc in swine and human respiratory epithelia 
Animal Neu5Ac (pmol/mg)a Neu5Gc (pmol/mg) 
Pigs 74.6 ±17.9 84.0 ±17.6 
Human 124 ±48.1 ND b 
Neu5Ac/Neu5Gc (mol/mol) 
47/53 
100/0 
"The concentration is expressed as the mean value ± standard deviation (n=S). 
bNot detected. 
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Fig. 1. Chromatograms of DMB derivatives of Neu5Ac and Neu5Gc obtained from tracheal epithelia of humans and pigs. The standard mix-
tures of Neu5Ac and Neu5Gc (A) and tracheal epithelia from humans (B) and pigs (C) were treated as described in Section 2. The fluorescence 
of DMB derivatives was detected at an excitation wavelength of 373 nm and an emission wavelength of 448 nm. Peak 1, Neu5Gc; peak 2, 
Neu5Ac. 
4. Discussion 
In this study, we investigated whether influenza viruses iso-
lated from swine recognize the major molecular species of 
sialic acid expressed on host respiratory epithelia. As shown 
in Table 1, the predominant presence of Neu5Gc, which had 
not been detected in human tracheal epithelia, was observed 
in swine tracheal epithelia. Accordingly, the binding activity 
of swine influenza viruses toward gangliosides containing dif-
ferent molecular species of sialic acid (Neu5Ac and Neu5Gc) 
was examined by a virus overlay assay on TLC. Swine influ-
enza viruses except for A/Iowa/15/30 (H1N1) exhibited ob-
vious binding activity toward Neu5GcGM3 as well as Neu5-
AcGM3. Similarly, the swine isolates bound to 
IV3Neu5GcnLc4Cer containing longer sialyloligosaccharides 
than Neu5GcGM3 (data not shown), whilst human strains 
exhibited poor binding activity for Neu5GcGM3. Previously, 
we demonstrated that the hemagglutination of human influ-
enza virus A and B strains was not inhibited by bovine sia-
lylglycoprotein, GP-2 containing I-active oligosaccharides 
with Neu5Gc as its predominate sialic acid, however, they 
were very sensitive to a GP-2 derivative to which Neu5Ac 
was reattached in a single and defined linkage by sialyltrans-
ferase, and which exhibited a specific inhibitory effect on the 
hemagglutination induced by A/PR/8/34 (H1N1) and A/Aichi/ 
2/68 (H3N2), which is 5-16 times higher than that of human 
glycophorin [17]. Accordingly, GP-2 was used to determine 
whether swine virus strains can bind sialylglycoproteins with 
Table 2 
Inhibition of swine 
Virus preparation 
and human influenza virus hemagglutination by glycoconjugate 
HAI titer1 
Neu5Aca2,3LacNAcPA 
polymers containing 2 types of sialo-sugar linkage 
Neu5Aca2,6LacNAcPA 
Swine isolates 
A/swine/Iowa/15/30 (H1N1) 
A/swine/Colorado/77 (H3N2) 
A/swine/Hokkaido/2/81 (H1N1) 
A/swine/Italy/309/83 (H3N2) 
A/swine/Kanagawa/1/92 (H1N2) 
Human isolates 
A/PR/8/34 (H1N1) 
A/Aichi/2/68 (H3N2) 
A/Memphis/1/71 (H3N2) 
16 
4 
2 
4 
2 
128 
4 
4 
2 
16 
32 
16 
16 
2 
64 
32 
The glycoconjugate polymers (1 mg/ml) were serially diluted (2-fold) with 25 |il of 0.02% (w/v) gelatin-PBS. The hemagglutination inhibition (HAI) 
assay was performed as described previously [15,17]. 
aHAI titers are expressed as the maximum dilution required to give complete inhibition of hemagglutination. 
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Fig. 2. Binding specificity of swine and human influenza virus strains to ganghosides containing different molecular species of sialic acid. Vari-
ous amounts of each ganghosides (Ac: Neu5AcGM3 and Gc: Neu5GcGM3), 0.5 nmol (lane 1), 1 nmol (lane 2), 2 nmol (lane 3), 4 nmol (lane 
4) were applied to a TLC plate. The plates were incubated with influenza virus suspension of 2s HAU in PBS at 4°C for 12 h, and then 
stained by a TLC/virus overlay assay as described previously, (a) Detected by resorcinol reagent; (b) A/swine/Iowa/15/30 (HlNl); (c) A/swine/ 
Hokkaido/2/81 (HlNl); (d) A/swine/Kanagawa/1/92 (H1N2); (e) A/PR/8/34 (HlNl); (f) A/Memphis/1/71 (H3N2). 
Neu5Gc-sugar chains as well as gangliosides. Three swine HI 
and 2 swine H3 isolates except for A/swine/Iowa/15/30 had 
remarkable binding abilities for GP-2 as compared with that 
of human influenza virus strains. These results suggest that 
the influenza A virus may preferentially recognize oligosac-
charides containing the molecular species of sialic acid which 
is presented predominantly in host cells. A proposal has been 
made that selection of receptor specific variants could result 
from selective binding of viruses towards host cells expressing 
complementary sialyloligosaccharide sequences [24-26]. In ad-
dition, it has been reported that the presence of Neu5Acoc2,6-
Galactose linkages on human ciliated cells and Neu5Ac2,3Ga-
lactose linkages in bronchial mucus secretions may combine 
and select for the hemagglutinin receptor specificity of human 
influenza A virus strains [10]. A/swine/Iowa/15/30 exhibited 
marked differences in their recognition of sialyl linkages and 
molecular species of sialic acid. The binding specificity of A/ 
swine/Iowa/15/30 might be changed by selective pressure on 
the allantoic membranes in a long-term passage. 
Recently, we have found that equine influenza viruses pref-
erentially bound to the sialyloligosaccharides containing 
Neu5Gc. In addition, the ratio of Neu5Gc to Neu5Ac in 
equine respiratory epithelia was higher than that of swine 
(described elsewhere). These results suggest that the binding 
specificity of influenza A virus for molecular species of sialic 
acid may be an important factor in restricting the virus host 
range. 
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Table 3 
Comparison of GP-2 binding activity of swine and human influenza A virus isolates 
Virus preparation VH titera 
GP-2 asialo-GP-2 
Swine isolates 
A/swine/Iowa/15/30 (HlNl) 
A/swine/Colorado/77 (H3N2) 
A/swine/Hokkaido/2/81 (HlNl) 
A/swine/Italy/309/83 (H3N2) 
A/swine/Kanagawa/1/92 (H1N2) 
Human isolates 
A/PR/8/34 (HlNl) 
A/Aichi/2/68 (H3N2) 
A/Memphis/1/71 (H3N2) 
<2 
32 
16 
<2 
<2 
<2 
<2 
<2 
<2 
<2 
<2 
<2 
<2 
<2 
aThe maximum dilution of virus showing hemadsorption was defined as the VH titer. As a control, each influenza virus was tested with asialo-GP-2 
immobilized in the wells instead of GP-2. 
Data represent the average of 3 determinations. 
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